The global trial run by researchers at Oxford and AstraZeneca has been paused due to an adverse reaction at a UK site. Whether the reaction is related to the vaccine is still unknown.
Two coronavirus vaccines show immune response in human trials
Scientists express cautious optimism about two potential COVID-19 vaccine candidates from the UK and China.
Vaccine candidate against COVID-19 shows early promise
Potential vaccine against COVID-19 could begin human trials after FDA approval.
Virus-scanning tool could detect previous COVID-19 infections and aid in vaccine development
SARS-CoV-2 is being added to VirScan’s library, a virus scanning tool that can identify thousands of past and present pathogens in a single drop of blood.
Modeling study estimates the impact of physical distancing on reducing the spread of COVID-19
Researchers provide evidence for the effectiveness of isolation and quarantine measures in minimizing the spread of COVID-19.
NIH clinical trial of investigational vaccine for COVID-19 begins
NIH clinical trial tests a new vaccine for COVID-19 in humans. While still in early stages, the team hopes to make it available as soon as possible.
Blocking key protein halts spread of cervical cancer tumors
New findings shed light on how cervical cancer spreads to the lymph nodes, opening the door for treatments that could stop the process.
Peptides light up in the brain for early diagnosis of Alzheimer’s
Peptide-laden vesicles light up in the presence of amyloid beta, providing an early diagnostic test (and possible treatment) for Alzheimer’s.
Cancer immunotherapy gets a boost from microbubbles
A fragile cancer immunotherapy agent “cGAMP” is delivered to tumor sites using tiny bubbles that protect it until it reaches its destination.
Corbevax vaccine offers solution to global vaccine inequity
The Corbevax COVID-19 vaccine was developed by researchers in Texas with no patent, and could be the end of global vaccine inequity.